From: Benefits of peritoneal ultrafiltration in HFpEF and HFrEF patients
 | Pre-pUFa | Post-pUFa | |||||||
---|---|---|---|---|---|---|---|---|---|
 | 3 months | P | 6 months | P | 12 months | P | Last follow up | P | |
NYHAd | |||||||||
 HFrEFb | 3.45 ± 0.52 | 2.80 ± 0.50 | < 0.001 | 2.79 ± 0.71 | 0.001 | 2.53 ± 0.75 | <  0.001 | 2.71 ± 0.72 | < 0.001 |
 HFpEFc | 3.19 ± 0.61 | 2.82 ± 0.56 | 0.002 | 2.44 ± 0.68 | 0.028 | 2.63 ± 0.69 | 0.045 | 2.72 ± 0.58 | <  0.001 |
Systolic BPe (mmHg) | |||||||||
 HFrEFb | 108.4 ± 18.7 | 111.2 ± 18.9 | 0.674 | 111.6 ± 18.9 | 0.846 | 117.0 ± 23.1 | 0.875 | 108.2 ± 23.2 | 0.284 |
 HFpEFc | 115.9 ± 20.7 | 120.1 ± 17.1 | 0.703 | 114.9 ± 20.6 | 0.680 | 110.1 ± 19.6 | 0.354 | 114.3 ± 22.8 | 0.799 |
Diastolic BPe (mmHg) | |||||||||
 HFrEFb | 68.4 ± 12.6 | 65.8 ± 11.7 | 0.001 | 67.2 ± 13.3 | 0.097 | 69.8 ± 17.0 | 0.270 | 66.3 ± 14.2 | 0.010 |
 HFpEFc | 67.1 ± 10.1 | 64.7 ± 7.18 | 0.542 | 66.5 ± 10.0 | 0.639 | 64.2 ± 12.3 | 0.752 | 64.0 ± 11.1 | 0.533 |
EFf (%) | |||||||||
 HFrEFb | 25.9 ± 6.82 | 29.0 ± 8.30 | 0.081 | 29.6 ± 8.75 | 0.154 | 31.1 ± 12.8 | 0.281 | 30.4 ± 12.2 | 0.046 |
 HFpEFc | 51.3 ± 7.77 | 48.2 ± 5.04 | 0.304 | 49.0 ± 4.56 | 0.404 | 47.0 ± 5.20 | 0.547 | 51.5 ± 8.86 | 0.189 |
Urine (ml) | |||||||||
 HFrEFb | 1172.3 ± 759.7 | 1408.4 ± 697.9 | 0.199 | 1319.1 ± 701.3 | 0.298 | 1263.4 ± 606.5 | 0.079 | 1051.0 ± 676.3 | 0.637 |
 HFpEFc | 1431.4 ± 1195.8 | 1118.3 ± 991.4 | 0.273 | 1225.0 ± 1198.9 | 0.522 | 1092.3 ± 818.5 | 0.764 | 984.6 ± 740.3 | 0.744 |
pUFa (ml) | |||||||||
 HFrEFb | nag | 1180.6 ± 1391.5 | nag | 1269.6 ± 1566.5 | 0.805 | 1020.3 ± 952.1 | 0.626 | 1306.8 ± 1284.7 | 0.870 |
 HFpEFc | nag | 979.7 ± 473.6 | nag | 982.6 ± 442.4 | 0.335 | 1140.6 ± 552.6 | 0.757 | 997.8 ± 546.6 | 0.359 |
Body Weight (kg) | |||||||||
 HFrEFb | 81.1 ± 14.6 | 76.7 ± 15.2 | < 0.001 | 77.4 ± 14.5 | 0.002 | 76.7 ± 14.3 | 0.068 | 77.2 ± 15.6 | 0.003 |
 HFpEFc | 86.9 ± 15.8 | 82.3 ± 13.3 | < 0.005 | 80.8 ± 11.0 | 0.023 | 83.2 ± 16.4 | 0.046 | 83.1 ± 15.9 | 0.005 |